NeuroOne® Ships Initial Zimmer Biomet Order for its Evo® sEEG System for Less than 30 Day Use
November 30, 2022
NeuroOne Introduces Advisory Board for Ablation Electrode Technology that Records and Ablates Brain Tissue Linked to Seizure Activity
June 2, 2021
Related Post
-
-
Nemaura Commences Pilot Program of Miboko with the NHS in the United Kingdom
November 29, 2022
-
Pressure BioSciences, Inc. Reports Q3 2022 Financial Results and Offers Business Update on Ultra Shear Technology Nanoemulsions Commercialization Progress
November 22, 2022
-
NeuroOne® to Ring Nasdaq Stock Market Closing Bell on November 22
November 22, 2022